A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.

Author: HarveyRebecca C, JamesAnthony C, ShieldsGemma E

Paper Details 
Original Abstract of the Article :
Early-onset schizophrenia (EOS) is a serious debilitating disorder with considerable morbidity and a reduced life expectancy; therefore, early diagnosis and effective treatments are particularly important. Negative symptoms are more prominent in adolescents and children (compared with adults), and a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40263-015-0308-1

データ提供:米国国立医学図書館(NLM)

Antipsychotics in Early-Onset Schizophrenia: A Journey Through the Desert of Mental Illness

Early-onset schizophrenia (EOS), a complex and debilitating mental disorder, presents unique challenges for patients and their families. Effective treatment options are crucial for improving outcomes in this vulnerable population. This systematic review and network meta-analysis explores the relative efficacy of antipsychotics for treating both positive and negative symptoms in EOS, focusing on studies using the Positive and Negative Syndrome Scale (PANSS).

Navigating the Sands of Antipsychotic Treatment in EOS

The review analyzed data from multiple studies comparing the efficacy of various antipsychotics in treating EOS. The findings suggest that different antipsychotics may have varying degrees of effectiveness in addressing both positive and negative symptoms. The review highlights the need for careful consideration of individual patient characteristics and symptom profiles when choosing an antipsychotic medication.

A Path to Improved Outcomes: Finding a Oasis in the Desert

This review underscores the importance of personalized treatment approaches for patients with EOS. The findings emphasize the need for a thorough assessment of symptoms and careful selection of medication based on individual patient needs. The review also highlights the ongoing need for research to develop more effective and targeted treatments for EOS, offering hope for a brighter future for patients and their families.

Dr. Camel's Conclusion

This systematic review and network meta-analysis provides a valuable guide for navigating the complex landscape of antipsychotic treatment for early-onset schizophrenia. The review emphasizes the need for a personalized approach, carefully considering individual patient characteristics and symptom profiles. This research is a testament to the ongoing efforts of scientists to refine and improve treatment options for mental illness, offering a glimmer of hope in the vast desert of mental health challenges.

Date :
  1. Date Completed 2016-10-31
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26801655

DOI: Digital Object Identifier

10.1007/s40263-015-0308-1

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.